D. Denton serves as the Chief Financial Officer (CFO) and Executive Vice President (EVP) at Pfizer Inc., a leading global pharmaceutical company. With a robust financial background, Denton has played a pivotal role in steering Pfizer's financial strategies and ensuring the company's sustained growth and profitability. Prior to joining Pfizer, Denton held several high-profile positions in the finance sector, where they honed their expertise in corporate finance, strategic planning, and financial risk management. At Pfizer, Denton's responsibilities encompass overseeing the company's global financial operations, including financial planning and analysis, accounting, tax, treasury, and investor relations. Their strategic vision has been instrumental in navigating the complex landscape of the pharmaceutical industry, particularly in managing the financial implications of research and development, mergers and acquisitions, and global market expansion. Under Denton's leadership, Pfizer has successfully implemented cost-saving initiatives and optimized its financial resources, which have significantly contributed to the company's financial health and competitive edge. Denton's achievements at Pfizer are numerous, including leading the company through several high-stakes financial transactions and ensuring compliance with international financial regulations. Their ability to balance short-term financial objectives with long-term strategic goals has earned them recognition within the industry and among Pfizer's stakeholders. As CFO and EVP, Denton continues to drive Pfizer's mission to deliver innovative healthcare solutions while maintaining financial stability and fostering growth.